PHRX | Pharmagen, Inc. Annual & Quarterly Income

Annual Income Statements

(In USD)

Breakdown	2013
Revenue	4813.05
Cost of Revenue	1767.84
Gross Profit	3045.21
Operating Expenses	6038.12
Selling, General and Administrative Expenses	5204.24
Research and Development Expenses	-
Other Expenses	-
Cost and Expenses	7805.96
Operating Income	-2159.03
Interest Expense	3 Million
Income Tax Expense	457.00
Earnings before Tax	-6000.61
Net Income	-6457.61
Earnings Per Share Basic	-0.02
Earnings Per Share Diluted	-0.02
Weighted Average Shares Outstanding	383.51 Thousand
Weighted Average Shares Outstanding (Diluted)	383.5 Thousand
Gross Margin	0.63
EBIT Margin	-0.43
Profit Margin	-1.34
EBITDA	-2.89 Million
Earnings Before Tax Margin	-0.45

Breakdown	2014 Q1	2013 FY	2013 Q4	2013 Q3
Revenue	1319.46	4813.05	1043.06	1073.66
Cost of Revenue	582.99	1767.84	401.37	400.64
Gross Profit	736.47	3045.21	641.69	673.02
Operating Expenses	804.45	6038.12	1994.59	1288.06
Selling, General and Administrative Expenses	1147.00	-	1417.58	1386.27
Research and Development Expenses	-	-	-	-
Other Expenses	-	-	-	-
Cost and Expenses	1387.45	7805.96	2395.96	1688.70
Operating Income	-410.52	-2159.03	-775.89	-713.25
Interest Expense	-	-	-	-
Income Tax Expense	100.00	457.00	457.00	-
Earnings before Tax	-712.60	-6000.61	-2310.62	-1347.26
Net Income	-812.60	-6457.61	-2767.62	-1347.26
Earnings Per Share Basic	-0.00	-	-0.01	-0.00
Earnings Per Share Diluted	-0.00	-	-0.01	-0.00
Weighted Average Shares Outstanding	480.54 Thousand	383.51 Thousand	396.05 Thousand	368.5 Thousand
Weighted Average Shares Outstanding (Diluted)	480.38 Thousand	383.5 Thousand	396.01 Thousand	368.4 Thousand
Gross Margin	0.56	0.63	0.62	0.63
EBIT Margin	-0.29	-	-0.71	-0.64
Profit Margin	-0.62	-1.34	-2.65	-1.25
EBITDA	-380.37	-	-742.27	-686.52
Earnings Before Tax Margin	-0.31	-0.45	-0.74	-0.66